Dr. Bhargavi Patham, M.D
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Years since graduation
- 28
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 202
Licensed in Texas since 2016, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
TX license Q7768 (first issued 2016; active) · TX license 1497041990 -
Internal Medicine Physician
TX license BP10040414
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Houston Methodist Hospital Houston, TX
- Houston Methodist Sugarland Hospital Sugar Land, TX
- Houston Methodist the Woodlands Hospital The Woodlands, TX
- Houston Methodist West Hospital Houston, TX
Medical groups
- Tmh Physician Associates PLLC (1,690 clinicians)
- Houston Methodist Specialty Physicians (1,528 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 202
- Services billed
- 601
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 123 | 87 |
| Established patient office or other outpatient visit, 20-29 minutes | 52 | 44 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 36 | 19 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 27 | 18 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 20 | 18 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 20 | 19 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 18 | 18 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Houston, TX | 100 |
| Metformin Hcl Other prescribers in Houston, TX | 68 |
| Lantus Solostar (insulin glargine,hum.rec.anlog) Other prescribers in Houston, TX | 62 |
| Atorvastatin Calcium Other prescribers in Houston, TX | 61 |
| Nano 2nd Gen Pen Needle (pen needle, diabetic) Other prescribers in Houston, TX | 59 |
| Rosuvastatin Calcium Other prescribers in Houston, TX | 54 |
| Novolog Flexpen (insulin aspart) Other prescribers in Houston, TX | 50 |
| Tradjenta (linagliptin) Other prescribers in Houston, TX | 45 |
| Mounjaro (tirzepatide) Other prescribers in Houston, TX | 44 |
| Ozempic (semaglutide) Other prescribers in Houston, TX | 41 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 2 payments worth $47.02 in total to this clinician.
| Ascensia Diabetes Care US Inc. | $24.61 |
|---|---|
| Abbott Laboratories | $22.41 |
| Food and Beverage | $47.02 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.